Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

    Stock Recap
    #PipelineProspector

    Menu

    Olanzapine Pamoate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    26/09/2024 Eli Lilly
    U.S.A
    		 Eli Lilly and Company 0002-1606 Olanzapine pamoate 2009-12-11 2024-12-31 DRUG FOR FURTHER PROCESSING INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (210mg/1.4mL)
    26/09/2024 Eli Lilly
    U.S.A
    		 Eli Lilly and Company 0002-2003 Olanzapine pamoate 2009-12-11 2024-12-31 DRUG FOR FURTHER PROCESSING INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (300mg/2mL)